NVRS.CN Noveris Health Sciences Inc.

P/E 0.026819924
Forward P/E --
Price/Sales --
Beta -5.515
Div Yield 0.0%
Market Cap --

Company Analysis

Latest News

πŸ”΄ Noveris Health Sciences is trading 11.76% down today amid broad biotech weakness and risk-off trading

Noveris Health Sciences is trading 11.76% down now at CA$0.07, continuing its decline from CA$0.09 on September 14, 2026, primarily amid broad biotech weakness...

πŸ”΄ Noveris Health Sciences is trading 5.88% down today as broad biotech weakness pressures shares

Noveris Health Sciences is trading at CA$0.08 and is down -5.88% amid broad biotech weakness and risk-off trading. - No new company-specific catalyst was...

🟒 Noveris Health Sciences is trading 5.88% up today with no clear company-specific catalyst identified

Noveris Health Sciences is trading 5.88% up at CA$0.09 on September 15, 2026, with no clear company-specific catalyst identified. - The latest reported...

πŸ”΄ Noveris Health Sciences is trading 10.53% down today

Noveris Health Sciences is trading 10.53% down at CA$0.09, with no clear company-specific catalyst identified for September 14, 2026. - The latest reported...

πŸ”΄ Noveris Health Sciences is trading 5% down today with no clear company-specific catalyst

Noveris Health Sciences is trading at CA$0.09, down -5.26%, with no clear company-specific catalyst identified for September 14, 2026. - The latest reported...

🟒 Noveris Health Sciences is trading 5% up today

Noveris Health Sciences is trading at CA$0.10, up +5.26%, with no clear company-specific catalyst identified for September 14, 2026. - The latest identified...

πŸ”΄ Noveris Health Sciences is trading 5% down today; no clear company-specific catalyst

Noveris Health Sciences is trading 5% down at CA$0.10, with no clear company-specific catalyst identified. - No clear September 11, 2026 company-specific...

🟒 Noveris Health Sciences is trading 5.26% up today β€” catalyst remains unclear

Noveris Health Sciences is trading 5.26% up at CA$0.10 in live trading data for September 10, 2026; no clear company-specific catalyst has been identified. -...

πŸ”΄ Noveris Health Sciences is trading 5.3% down today as hotter August producer inflation raises rate concerns

Noveris Health Sciences is trading at CA$0.09, down -5.26%, as broader risk-off pressure intensified on September 10, 2026. β€’ U.S. indices are down more than...

πŸ”΄ Noveris Health Sciences is trading 14.29% down today amid broader risk aversion

Noveris Health Sciences is trading 14.29% down at CA$0.09 amid broader risk aversion, after falling from the September 8 close of CA$0.10. - No new...

πŸ”΄ Noveris Health Sciences is trading 9.52% down today with no confirmed catalyst identified

Noveris Health Sciences is trading at $0.10, down -9.52%, with no new company-specific announcement or confirmed catalyst identified for September 9, 2026. -...

πŸ”΄ Noveris Health Sciences is trading 21.74% down today with no clear company-specific catalyst identified

Noveris Health Sciences is trading 21.74% down at $0.09, with no clear company-specific catalyst identified for September 8, 2026. - Recent disclosures...

🟒 Noveris Health Sciences is trading 8.7% up today with no clear catalyst identified

Noveris Health Sciences is trading at $0.12, +8.70% now, with no clear September 8, 2026 catalyst identified. β€’ Recent company disclosures include Q2 net...

🟒 Noveris Health Sciences is trading 13.04% up today amid biotech momentum after Purple Biotech’s patent allowance

Noveris Health Sciences is trading at $0.13, up 13.04%, on broader biotech-sector momentum. - Available coverage links the sentiment to Purple Biotech’s U.S....

🟒 Noveris Health Sciences is trading 13.04% up today on biotech momentum, with no clear catalyst

Noveris Health Sciences is trading higher on September 3, 2026, at CA$0.13, up 13.04%, as sector momentum supports the move despite no clear company-specific...

🟒 Noveris Health Sciences is trading 8.7% up today as biotech strength supports risk appetite

Noveris Health Sciences is trading at CA$0.12, up +8.70%, mainly as biotech-sector strength supports risk appetite; no clear company-specific catalyst has been...

πŸ”΄ Noveris Health Sciences is trading 8.33% down today β€” no clear catalyst identified

Noveris Health Sciences is trading 8.33% down at $0.11, with no clear company-specific catalyst identified for September 2, 2026. - Available market coverage...

πŸ”΄ Noveris Health Sciences is trading 14.81% down today as biotech ETF XBI falls 4.24%

Noveris Health Sciences is trading 14.81% down at $0.12 amid broad biotech weakness and a risk-off market session. - Major indexes are also lower as investors...

πŸ”΄ Noveris Health Sciences is trading 7.41% down today as biotech weakness weighs on speculative healthcare shares

Noveris Health Sciences is trading at $0.12 (-7.41%) as biotechnology weakness and a broader risk-off session weigh on speculative healthcare shares. - No new...

πŸ”΄ Noveris Health Sciences is trading 13.33% down today amid broad biotech weakness

Noveris Health Sciences is trading 13.33% down at $0.13 amid broad weakness in biotechnology. - The XBI ETF was down 4.24% during the regular session. - No...